GE HealthCare, Elekta join forces to enhance cancer treatment in India

GE HealthCare, a prominent global player in the medical technology and diagnostics sector, is broadening its partnership with Elekta, a leading name in radiation therapy, in India.

This collaboration aims to expand accessibility to precision radiation therapy solutions, offering hospitals a comprehensive package for cancer patient diagnostics and treatment requiring radiation therapy.

As an integral part of cancer care, radiation therapy is necessary for more than 50% of patients. The World Health Organization (WHO) suggests a ratio of one medical linear accelerator (a machine used for cancer treatment in radiotherapy) per million people in developing nations.

Currently, in India, the availability stands at a mere 0.4 per million, indicating a crucial need to improve access to quality care and enhance patient outcomes.

By combining GE HealthCare’s diagnostic solutions with Elekta’s radiation therapy solutions, a compelling proposition will be presented to hospitals and, ultimately, their patients. The collaboration marks a significant stride in GE HealthCare’s ongoing commitment to establishing an ecosystem where cancer care sees continuous improvement.

Over the years, GE HealthCare has fortified numerous collaborations, bringing together complementary solutions and technologies along the radiation therapy treatment pathway. Its partnership with Elekta in India serves as a testament to its dedication to ameliorate cancer outcomes with various partners and providers.

As a pioneer of precision radiation therapy solutions, Elekta’s treatment modalities demand excellent precision and accuracy in delivering radiation to the tumor, while also safeguarding surrounding healthy tissue and organs.

GE HealthCare and Elekta collaborate in India to enhance access to precision radiation therapy. Photo courtesy of Business Wire India.

Manikandan Bala — Elekta Senior Vice President of TIMEA & Asia Pacific and Managing Director of India & South Africa said: “Delivering precision radiation therapy requires advanced patient positioning, motion management technologies, and state-of-the-art radiation therapy techniques.

“Elekta’s and GE HealthCare’s combination of radiation therapy solutions and diagnostic imaging will enable healthcare providers to deliver precise and personalized therapies that treat tumors effectively while sparing adjacent tissue and organs at risk. Together, these advanced offerings are designed to improve outcomes and increase the quality of life for patients.”

GE HealthCare’s innovative portfolio of diagnostic and treatment technologies are devised to enhance detection, clinical efficiency, operational efficiency, and outcomes for cancer patients.

Chaitanya Sarawate — GE HealthCare South Asia President and CEO and Wipro GE Healthcare Managing Director said: “We continue to expand our oncology offerings through strategic collaborations in adjacent fields that are also leaders in their disciplines. Through this collaboration with Elekta our vision is to enable more efficient, precise and personalized care across the cancer care continuum.

“We will remain focused on investments that can deliver the best cancer care, offering solutions that transform and humanize care.”